Upon completion of the module, the participant will:
Schedule:
Personalizing cancer drug selection: pathology stains, genes and living cells | Larry Wiesenthal, MD | 4 hr |
Cell signaling pathways, targeted agents and synergistic botanicals, implications for cancer treatment, with specific discussion of breast, lung, kidney and prostate cancer, myeloma, melanoma, and glioblastoma multiformae | Dwight McKee, MD | 6 hr |
Cancer and Insulin | Barry Boyd, MD | 3 hr |
Advances in Image Guided Cancer Ablation | Jason Williams, MD | 1 hr |
3-BP | Jason Williams, MD | 1 hr |
Immuno and Gene Therapy | Jason Williams, MD | 1 hr |
Laetrile, Amygdalin and Cyanogenic Glycodsides in the Treatment of Cancer: Past, Present and Future | Ralph Moss, PhD | 3 hr |
The Effects of Surgery on Tumor Growth: A Century of Investigations | Mark Rosenberg, MD | 1 hr |
Evolutionary Dynamics of Cancer | Robert Gillies, MD | 3 hr |
Glioblastoma | Mark Rosenberg, MD | 1 hr |